Park Square has placed Debbie Chirnomas as Chief Medical Officer at Faeth Therapeutics.
| less than a minute read
Faeth Therapeutics Appoints Debbie Chirnomas, M.D., M.P.H., as Chief Medical Officer
Get in touch
Get in touch
“Dr. Chirnomas will help the company advance our pipeline of metabolically-driven therapeutics targeting multiple cancers. Debbie comes to Faeth with years of experience in clinical development and medical affairs, which we look to leverage as we continue the clinical development of our lead assets,” said Anand Parikh, J.D., Chief Executive Officer of Faeth Therapeutics.
Get in touch
Get in touch
Latest Insights
